Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Cash and cash equivalents
Restricted cash	$ 549	$ 544
Securities purchased under resale agreements	307	318
Accumulated depreciation and amortization	10,233	9,850
Other assets, reserves for credit losses	25	22
Liabilities
Long-term debt	$ 41,138	$ 42,573
Shareholders’ Equity
Preferred shares, par value (in dollars per share)	$ 1.667	$ 1.667
Preferred shares authorized (in shares)	20,000,000	20,000,000
Preferred shares, issued (in shares)	1,600	1,600
Preferred shares, outstanding (in shares)	1,600	1,600
Common shares, par value (in dollars per share)	$ 0.20	$ 0.20
Common shares, authorized (in shares)	3,600,000,000	3,600,000,000
Common shares, issued (in shares)	743,000,000	743,000,000
Common shares, outstanding (in shares)	743,000,000	743,000,000
Card Member Receivables
Cash and cash equivalents
Financing receivables, gross	$ 57,494	$ 57,613
Allowance for credit losses	223	229
Card Member Loans
Cash and cash equivalents
Financing receivables, gross	109,050	107,964
Allowance for credit losses	4,053	3,747
Other Loans
Cash and cash equivalents
Allowance for credit losses	83	59
Variable Interest Entity, Primary Beneficiary
Cash and cash equivalents
Restricted cash	3	5
Restricted investments	54	54
Liabilities
Long-term debt	11,665	12,662
Variable Interest Entity, Primary Beneficiary | Card Member Receivables
Cash and cash equivalents
Financing receivables, gross	5,336	5,193
Variable Interest Entity, Primary Beneficiary | Card Member Loans
Cash and cash equivalents
Financing receivables, gross	$ 27,098	$ 28,461